Because GITR was expressed most prominently on CD4+ and CD8+ TIL, in functional assays we focused on co-stimulatory receptor targeting via agonistic GITR ligation in pMMR CRC and CRLM patients. Here, TNFRSF18 is linked to colorectal carcinoma.